Abstract

State of the Art in Drug Trials.- Evaluating Antidepressants and Anxiolytics.- Testing the Efficacy of New Neuroleptic Drugs.- Evaluation of Drugs in Alzheimer's Disease and Age-Associated Memory Impairment.- Testing the Efficacy of New Hypnotic Drugs.- Placebo-Controlled Trials and Ethical Issues.- Placebo-Controlled Studies in Depression: Necessity and Feasibility.- Ethical Problems and Design of Controlled Clinical Trials.- Biostatistics and Measurement of Drug Effects.- Statistical Issues: Sample Size and Dropout.- Measuring the Efficacy of Psychotropic Drugs: Clinical Symptoms and Rating Scales.- Methodological Problems in Assessing Quality of Life as Outcome in Psychopharmacology: A Multiaxial Approach.- Ascertainment of Side Effects in Psychopharmacologic Clinical Trials.- Selection Criteria for Drug Trials.- Diagnoses as Selection Criteria in Drug Trials.- Functional Classification and Response to Psychotropic Drugs.- Append.- National and International Guidelines for the Conduct of Clinical Trials of Psychotropic Drugs.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.